Recombinant anti-CD25 humanized monoclonal antibody
- Generic Name
- Recombinant anti-CD25 humanized monoclonal antibody
Anti-CD25 rhMAb for aGVHD Prevention in High-Risk Adults Using the daGOAT Model
Phase 2
Not yet recruiting
- Conditions
- Acute Graft-versus-Host Disease
- Interventions
- First Posted Date
- 2025-03-17
- Last Posted Date
- 2025-03-17
- Target Recruit Count
- 174
- Registration Number
- NCT06880419
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath